Studies demonstrate its ability to stimulate cell migration and tendon fibroblast activity, leading to improved tendon outgrowth and repair, particularly in injuries like Achilles tendon ruptures (2)
Wegovy belongs to the GLP-1 receptor agonist category
On the other hand, its glucagon-based action could help the body burn more fat, including harmful visceral and liver fat
The specific amount of weight loss varies by person, but patients taking these medications typically see about 6% to 11% weight loss
It needs to build up in your system over weeks
For example, if important biomarkers such as waist circumference, blood pressure, and heart rate are improving, thats proof that your GLP-1 journey is working, he says